Dr. Falk Pharma GmbH (responsible for batch release of the final product)
UkraineAll drugs from this manufacturer
-
The drug is used for chronic constipation, irritable bowel syndrome, and in cases where soft and easy bowel movements are required (e.g., in hemorrhoids, anal fissures, or after rectal surgery). It is also used as an adjunct therapy for high cholesterol levels.
Dosage form: granules
Active substance Dosage psyllium seed husk 3.25 g -
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Dosage form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 3 g ATC: A07EC02
-
The drug is used for the treatment of exacerbations and the prevention of relapses of mild to moderate ulcerative colitis.
Dosage form: granules, gastroresistant prolonged-release
Active substance Dosage mesalazine 1.5 g ATC: A07EC02
-
The drug is used to treat exacerbations of ulcerative colitis (a chronic inflammatory disease of the large intestine).
Dosage form: suspension, rectal
Active substance Dosage mesalazine 4 g ATC: A07EC02
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum, as well as to maintain remission of this disease.
Dosage form: suppositories, rectal
Active substance Dosage mesalazine 250 mg ATC: A07EC02
-
The drug is used to treat exacerbations of ulcerative colitis limited to the rectum, as well as to maintain remission of this disease.
Dosage form: suppositories, rectal
Active substance Dosage mesalazine 500 mg ATC: A07EC02
-
The drug is used to dissolve cholesterol gallstones (up to 15 mm in size), to treat primary biliary cirrhosis, and to treat liver and bile duct disorders in children with cystic fibrosis.
Dosage form: suspension, oral
Active substance Dosage ursodeoxycholic acid 250 mg/5 ml -
The drug is used to dissolve cholesterol gallstones (up to 15 mm in size), to treat biliary reflux gastritis, for primary biliary cirrhosis, as well as for the treatment of liver and biliary tract disorders in children with cystic fibrosis.
Dosage form: capsules
Active substance Dosage ursodeoxycholic acid 250 mg -
The drug is used to dissolve cholesterol gallstones (up to 15 mm in diameter), to treat primary biliary cirrhosis, and to treat biliary tract disorders in children with cystic fibrosis.
Dosage form: tablets, film-coated
Active substance Dosage ursodeoxycholic acid 500 mg